Alternate Vial Label 1 (1459 1 Alternate Vial Label 1)
Amidate(tm) Etomidate Injection, Solution
Product Images NDC 51662-1459
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amidate(tm) Etomidate (NDC 51662-1459). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Serialized Vial Labeling (1459 1 Serialized Vial Labeling)
This is a description of medicine named "Etomidate Injection, USP" that comes in a 10 mL single-use flip-top vial with a concentration of 20mg/10 mL (2 mg/mL). It is for intravenous use only and distributed by Hospira, Inc. The package includes manufacturer's insert and it is RX only. There are some numbers and codes mentioned as well.*
Surerseeded Vial Label (1459 1 Superseeded Vial Label)
This is a description of a medication called Etomidate Injection, which is in a single-dose vial. The vial contains 10mL of the medication, with each mL containing 2mg of Etomidate, as well as 35% v/v propylene glycol. It is intended for intravenous use only and is manufactured by Hospira, located in Lake Forest, IL.*
Vial Label (1459 1 Vial Label)
This is a 10 mL single-dose Fliptop vial with NDC code 0409-6695-11. It contains Etomidate Injection, USP with a strength of 2mg. It is sterile, non-pyrogenic, and intended for intravenous use only. It is distributed by Hospira, Inc. in Lake Forest, IL 60045, USA, and is accompanied by an insert with information to help ensure proper usage.*
Alternate Vial Label 2 (Alternate Vial Label 2)
This text appears to be a description of Etomidate Injection, which comes in a 0 mL single-dose flip-top vial with an NDC number of 0409-6695-11. Each mL of the injection contains 2mg of etomidate and 35% propylene glycol. The injection is sterile and nonpyrogenic, and is intended for intravenous use only. The recommended dosage should be found in the insert, and any unused portion should be discarded. The product is distributed by Hospira, Inc. in Lake Forest, Illinois.*
How Supplied (How Supplied)
This is a description of the unit of sale concentration of three different products. The first two products contain 20 mg/10 mL and 40 mg/20 mL of an unknown substance respectively, and are sold in trays containing 10 fliptop vials. The third product contains 40 mg/20 mL of the same substance and is sold in a bundle containing 10 Abboject syringes with a male luer lock adapter.*
Logo (Logo)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
